Kusta Tipe Multibasiler dengan Erythema Nodosum Leprosum Selama Pengobatan Disertai Diabetes Melitus Tipe 2 dan Anemia
DOI:
https://doi.org/10.55606/jig.v4i2.8918Keywords:
Anemia, Diabetes Mellitus, ENL, Leprosy, Mycobacterium LepraeAbstract
Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an obligate intracellular bacterium that affects the skin, peripheral nerves, upper respiratory mucosa, and eyes. Type 2 diabetes mellitus (T2DM) is a comorbidity that can worsen the course of leprosy. The female patient, Mrs. D, aged 55 years came to the emergency room of Cut Meutia Hospital with the main complaint of red bumps accompanied by pain on the face, hands, chest, and back since 3 days ago and additional complaints such as fever, joint pain, and numbness and loss of feeling in the legs, weakness, frequent thirst, and frequent urination. Dermatologic status is obtained in the facial region in the form of erythema nodules with firm boundaries with numular size, multiple. Laboratory examination showed anemia and leukocytosis. The therapy given was MDT MB package, ferrous sulfate 1x325 mg and PRC transfusion 3 kolf. Complaints arose acutely after the patient resumed taking MDT (multidrug therapy) leprosy drugs which had previously been stopped for more than 3 months. Based on the time of onset of symptoms, history of leprosy treatment, and the manifestation of systemic inflammatory lesions with signs of neurotropism, it can be suspected that the patient is experiencing a type 2 leprosy reaction or Erythema Nodosum Leprosum (ENL).
Downloads
References
American Diabetes Association . (2021). Classification and diagnosis of diabetes: Standards of medical care in diabetes—2021. Diabetes Care, 44(Suppl. 1), S15–S33. https://doi.org/10.2337/dc21-S002
Bhat, R. M., & Vaidya, T. P. (2020). What is new in the pathogenesis and management of erythema nodosum leprosum. Indian Dermatology Online Journal, 11(4), 482–492. https://doi.org/10.4103/idoj.IDOJ_561_19
Del Arco, R., Nardi, S. M. T., Bassi, T. G., & Paschoal, V. D. A. (2016). Diagnosis and medical treatment of neuropathic pain in leprosy. Revista Latino-Americana de Enfermagem, 24, e2731. https://doi.org/10.1590/1518-8345.0676.2731
Dewi, D. A. R., Djatmiko, C. B. P., Rachmawati, I., et al. (2023). Immunopathogenesis of type 1 and type 2 leprosy reaction: An update review. Cureus, 15(11), e49155. https://doi.org/10.7759/cureus.49155
Ibrahim, M. I. S., Mohamad, H., Mohamad, A., & Mohamad, I. (2020). Association between neck circumference and the severity of obstructive sleep apnea. Polish Annals of Medicine, 27(1), 1–6. https://doi.org/10.29089/2020.20.00097
Leon, K. E., Walker, S. L., Lockwood, D. N. J., et al. (2015). Complex type 2 reactions in three patients with Hansen’s disease from a southern United States clinic. The American Journal of Tropical Medicine and Hygiene, 93(4), 801–805. https://doi.org/10.4269/ajtmh.15-0052
Li, X., Ma, Y., Li, G., Jin, G., Xu, L., Li, Y., et al. (2024). Leprosy: Treatment, prevention, immune response and gene function. Frontiers in Immunology, 15, 1298749. https://doi.org/10.3389/fimmu.2024.1298749
Lotterman, S., & Sharma, S. (2023). Blood transfusion. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK499824/
Medscape. (2023). Chronic anemia medication: Iron products, vitamins. Retrieved from https://emedicine.medscape.com/article/780176-medication
Mehta, H., Jain, S., Narang, T., Chhabra, S., & Dogra, S. (2024). Leprosy reactions: New knowledge on pathophysiology, diagnosis, treatment and prevention. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/IJDVL_915_2024
Pinheiro, R. O., Rosa, P. S., Spencer, J. S., & Soares, C. T. (2022). Editorial: Leprosy reactions: New knowledge on pathophysiology, diagnosis, treatment and prevention. Frontiers in Medicine, 9, 1072274. https://doi.org/10.3389/fmed.2022.1072274
Riley, D. S., Barber, M. S., Kienle, G. S., Aronson, J. K., von Schoen-Angerer, T., Tugwell, P., ... & Gagnier, J. J. (2017). CARE guidelines for case reports: Explanation and elaboration document. Journal of Clinical Epidemiology, 89, 218–235. https://doi.org/10.1016/j.jclinepi.2017.04.026
Scollard, D. M., Adams, L. B., Gillis, T. P., Krahenbuhl, J. L., Truman, R. W., & Williams, D. L. (2006). The continuing challenges of leprosy. Clinical Microbiology Reviews, 19(2), 338–381. https://doi.org/10.1128/cmr.19.2.338-381.2006
Wang, Y., Zhang, L., Li, X., & Chen, H. (2021). Host-related laboratory parameters for leprosy reactions. Frontiers in Medicine, 8, 694376. https://doi.org/10.3389/fmed.2021.694376
Weiss, G., & Ganz, T. (2019). Anemia of inflammation. Blood, 133(1), 40–50.
World Health Organization. (2024). Leprosy. https://www.who.int/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ary Fadhil Maulana, Muhammad Mimbar Topik

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.








